David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE ○  	A “Founding Father” of Diabetes Technology  ■  	AI Health Advisor and Member of the AI Health Clinical and Technical Oversight Board.   ○  	The Doctor who Coined the Term “Diabetes Technology”  ■  	Dr. Klonoff is a practicing endocrinologist specializing in the development and use of diabetes technology – a term he coined.   A pioneer in this area, he not only founded the Diabetes Technology Meeting and the Hospital Diabetes Meeting, but also is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and is senior editor of the first book about diabetes digital health.   ○  	 Educating Future Generations ■  	Dr. Klonoff is also Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at University of California San Francisco.    ○  	“Among the top 2% of the world’s Bioengineers” ■  	Dr. Klon

The Doctor who Coined the Term "Diabetes Technology"

Dr. Klonoff is a practicing endocrinologist specializing in the development and use of diabetes technology – a term he coined.   A pioneer in this area, he not only founded the Diabetes Technology Meeting and the Hospital Diabetes Meeting, but also is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and is senior editor of the first book about diabetes digital health.

The Doctor who Coined the Term "Diabetes Technology"

Dr. Klonoff is a practicing endocrinologist specializing in the development and use of diabetes technology – a term he coined.   A pioneer in this area, he not only founded the Diabetes Technology Meeting and the Hospital Diabetes Meeting, but also is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and is senior editor of the first book about diabetes digital health.

The Doctor who Coined the Term "Diabetes Technology"

Dr. Klonoff is a practicing endocrinologist specializing in the development and use of diabetes technology – a term he coined.   A pioneer in this area, he not only founded the Diabetes Technology Meeting and the Hospital Diabetes Meeting, but also is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and is senior editor of the first book about diabetes digital health.

"Among the top 2% of the world's Bioengineers"

Dr. Klonoff has long been regarded as one the leaders in the field of diabetes technology.   In 2019, he was recognized with the American Diabetes Association’s Outstanding Physician Clinician Award.  He also received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. In 2012 Dr. Klonoff was elected as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and cited as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology.  His experience in the area of Diabetes and Technology is vast as he has chaired or served on 58 grant review panels including for NIH, CDC, NASA, NSF, US Army, NOAA, ADA, and JDRF; plus agencies in ten foreign countries.  He chaired the first and second CLSI POCT05 Performance Metrics for Continuous Interstitial Glucose Monitoring Panel, the Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline, and the Continuous Ketone Monitoring Panel. He has authored over 270 publications in PubMed journals including four of the first ten articles on diabetes device cybersecurity, is Chair of the IEEE 2621 Standards for Wireless Diabetes Device Security Assurance Committee, and he chaired DTSec and DTMoSt — the world’s first and second consensus medical device cybersecurity standards. He has been a Principal Investigator in over 120 clinical trials of diabetes drugs and devices.

David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE

AI Health Advisor and Member of the AI Health Clinical and Technical Oversight Board

Francisco J. Pasquel, MD, MPH

AI Health Advisor and Member of the AI Health Clinical and Technical Oversight Board

Medical Advisory Team

Educating

Future Generations

Dr. Klonoff is also Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at University of California San Francisco.

David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE ○  	A “Founding Father” of Diabetes Technology  ■  	AI Health Advisor and Member of the AI Health Clinical and Technical Oversight Board.   ○  	The Doctor who Coined the Term “Diabetes Technology”  ■  	Dr. Klonoff is a practicing endocrinologist specializing in the development and use of diabetes technology – a term he coined.   A pioneer in this area, he not only founded the Diabetes Technology Meeting and the Hospital Diabetes Meeting, but also is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and is senior editor of the first book about diabetes digital health.   ○  	 Educating Future Generations ■  	Dr. Klonoff is also Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at University of California San Francisco.    ○  	“Among the top 2% of the world’s Bioengineers” ■  	Dr. Klon
Portrait os David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE. He is an older male who is smiling. Wearing a gray coat, blue striped collard shirt, gray glasses and a blue and gold necktie. He is bald with gray hair.
San Francisco city skyline. Multiple skyscrapers in view. Oakland Bay Bridge is in the background. The triangular Transamerica building is in the center. It is a clear sunny day.

A "Founding Father" of Diabetes Technology

David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE

AI Health Advisor and Member of the AI Health Clinical and Technical Oversight Board